{"name":"Synnovation Therapeutics, Inc.","slug":"synnovation-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQak5aQWtZcElPa0hZN29GUV8yTGdYZGg0TmtOZmdFMDNTTm50cklhaUdIYVZYeDM3TEdoSTI3MnRsaGdsNWNTS0kxNGs4OFFQRXhXVmFaVXJvb2hHMjE5YldDVVBUODZsMlR3UzVfYnQzYW54cUNzamh4aWJNdmp1MEtvNFJNaWVYZHFpcmE0ejFQV2VwZ1Bydkt0YVV2Sy1xZ3BKaXJLVEMtZUFzMHZBTlZKeUU?oc=5","date":"2026-04-06","type":"earnings","source":"TradingView","summary":"Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines - TradingView","headline":"Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWDVEZ0VCRW93QVE2YVJvWmVXR0JOdXNwaWxBVnFCUW1IRkg1Q3l3Nm9ZNVVocHJJUi1GUjF6MHBoZWJyZG5jTFJRQWxYZVJHMllpcjZUT3JCc3ZqSlhyQ1p0aGphUU9sZi14YmNDRzMwWnc2TE52NmlPMmFhMzN2R3dIVjQxeTl5WHdB0gGQAUFVX3lxTE9vdDRvQ3F5dFdaem0yUkFGTVFRdEI0ZE5EeWxtUzRiTk9GQTVxcllvenpMMEdQYm1ERWxiRUJORmtFUTU1WFY5Q2ZlaGJ3LTJzUnprZGVfZUJWUzJIT0JaV01iZ2VNSlhLTko5TWp1RFFEbFQ2dThPTTFvVFpXMGwwWWgtVENvWHFwd3ZVUTdLcA?oc=5","date":"2026-03-27","type":"deal","source":"CNBC","summary":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week - CNBC","headline":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZ2tZd0Q5RWRocVJCMHg4dkVDZFVSa2hsWjRJeXNVVm1HLUp6UHo0a2lMdEgzMl9hOWtJRjZnVUJHRmdCcUtqUl9PXzJzbENUdXNHRTQ5WkVIVnlrZHVFYVJXSmlHV0dBNkFlOXR6dHFCa1hpZnE0N3B0dFh1RTZXdFdOZF9FVHJjWTk3aXNTZkl4U0tDY2UteXo1YWdEdGNhTU5uM3VfamdZeVFlZHdldmd2dlB2ZmQ4bnpLTg?oc=5","date":"2026-03-23","type":"pipeline","source":"MedCity News","summary":"Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own Products - MedCity News","headline":"Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own Products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbXBGY2toZ1liczV5bVRZTW9JbkFiVmhrY2J1WG52RXJjTWFJNjk0b2hrRTJWUWgyU2tZN0RUczRQbE9Fa3lzek55SmNobFg1cmloQ0RuRUJIN2tCX2h0ay1MTGJ2em1hUUYwc0xoT2RmMno5bGx0bERZSU9rNjFSdUZrdzc0YnNjZGctb3RyXzRuUmxveTU3WWJUR0JHVjJkVGVqV2NpSU1zV3pkamZrQkVWX3ZqQjVxWFFlaUdpWU9BSXdPMFNoRFZNbE90ZjJVMWo3QjNYTVc5WjlWdlE?oc=5","date":"2026-03-20","type":"deal","source":"Business Wire","summary":"Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program - Business Wire","headline":"Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNZ3o0V2tWLUQtRXJuSXdVVjk5Z3gtTXZlb2RRbjRUc1gyOHRKbWUwelQxRXlxVzVGOVNtUk5tZENIckw1aEVqRVZoZnBmd1FyMHJzVG1iOWQtLUxLMWJONk5IYkY5YWVfVDE3ZG05LTFhOVdIcFB3VUhrVFBKdFlaVG5lTjZPaXJHcWYwN25aVjJuRlN2aU1FQQ?oc=5","date":"2026-03-20","type":"pipeline","source":"statnews.com","summary":"Novartis picks up experimental breast cancer therapy for $2B - statnews.com","headline":"Novartis picks up experimental breast cancer therapy for $2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVZUR244cms5M2xJUUZNbFRVUHNuOWZqczc2dzdrV21GR20yamFiRjdsVXNFY19UTjZpclNmVGFOQTBldFpBOGZtd2pvbHRBV0hkZjlhdU1BelEwZFhPLXJOUFFMS0puTDFBNWUzM2xtVy11MngyQVhXNkNyZ2VDTUtYWnh0TlVIUWloOXRxVlgxN0VZQV90bnowNEdwR3FuUW9TVjNtNA?oc=5","date":"2026-03-20","type":"pipeline","source":"European Pharmaceutical Review","summary":"Novartis strengthens its breast cancer pipeline with $3bn Synnovation acquisition - European Pharmaceutical Review","headline":"Novartis strengthens its breast cancer pipeline with $3bn Synnovation acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQT2lHNWFaNGp4M1ZvU3hGUk5hdmRaeThmLWhtaVVDenF1SEMxTDVpcGhSX1JweXVUbm8zNzRuZWpZSm01RVRzMEZfRkxPUzljNEgtS1BpVFFpMjRzM1FxdlY4OEREVktEZS1WcFNtWnRaVjBRNC0tMXV5U3hpWlN6UmRKZEF4ZHpXNUNBMElBdS1NbUJOalVneHNoc1l3alVhU3FXOGlfcGNDX204NXBrbVpQMDdzRHp0Qmp0ME96NUVrRzg?oc=5","date":"2026-03-20","type":"deal","source":"Reuters","summary":"Novartis to buy experimental breast cancer drug in up to $3 billion deal - Reuters","headline":"Novartis to buy experimental breast cancer drug in up to $3 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNXzJNR3FNRzBMeWNUMGZIR0l6dEhOU2FVb09hNjY1Z21kb1N3dzcxNzBFVl9xUVZTQi1wWUl4N0NrUlM5ZnpjRVVPRmRaRk5XUk51aHR1amtvMkk0VWFTLUxOcjhHLXk5M0dERlpEaFQ4T1UySDJRTlZzS2pXSGx0a0FfMm9qVVI1eTlHYVM0OE10Z281SEFvTUExWl9ob2l0UFZ0YmNfNW5rQmhFeFpMYjdLU2NLWktsVXhYOGJkWVp2VThCY2xMNnV5cFd0eXdmaXl0WHpJaXpEa2lzcjR2NU05VTJzLUxPLThB?oc=5","date":"2026-03-20","type":"deal","source":"Pharmaceutical Executive","summary":"Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics - Pharmaceutical Executive","headline":"Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQTzBKdHFuVkxWdlQ0VGdTNWN6NlpKb3RFcGZKVnhhdkNqQUUxekI2NllMa0hnNGt5VWtyaHpCTUp1VGpLT2lYNURTQnI1WDhvdlROU0dQWTY5ZWk4RFVJUjJRRFljdzVBX3BZSHpHRjVnZDZsVTZ3bTZFT0dJOGh0YjRIRk5hQmQxampSR0duSHU5azgtUm1FVVIzU3JvRjB3d0E?oc=5","date":"2026-03-20","type":"deal","source":"BioSpace","summary":"Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals - BioSpace","headline":"Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdjNXMDdRc05HdllsaFFlZF9wSEVTVU5KbG83QnVzYllPZDNqMGhyYXFlcGw5NldzM1RUZEdkcDgxSms5THJYTlBnNm9RLVZxejl1MUswcGhNZ2MzSm5XT2YtQlFCZWpSTG95Sm15RWpCaHh2YVR6WXlBSWd2X1RGNkkzVHJLM2lGZnZjSE5iSHM3a2dOUUd1NThxNA?oc=5","date":"2026-03-20","type":"pipeline","source":"BioPharma Dive","summary":"Novartis pays $2B to land a startup’s breast cancer drug - BioPharma Dive","headline":"Novartis pays $2B to land a startup’s breast cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOckp6LVVyTUk4bGc1MjNlUlZxSmpiU09OREsySGczSWpnUlJneE5XbkZRNGRWUUpTSHI2LXktT1J6b3U2cHNOa1pKSVFNMXNSZ293VGxreS1aTHRENkxOX3hzckZ0UkdCc2VCdlhPOTZYTXljWmZuV29haHlocDBNMldNVC1mejhOYkdORkxodXk1WnJGc2FJTHdQR0hxY0Nna0VkUWdyUnlBblF4UVBuNVdNNA?oc=5","date":"2026-03-20","type":"deal","source":"Bloomberg.com","summary":"Novartis to Buy Breast Cancer Drug for as Much as $3 Billion - Bloomberg.com","headline":"Novartis to Buy Breast Cancer Drug for as Much as $3 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOZGt3elZYT09SdDdmTW13b1FtOUpxbEdUT2NCWktJakpDWlpPejJsak93Ti1GYXN3WXpxM2JudzJMUFNpZVhTcENRNy14UWhGRUplUFhGeW9XMTlSeUNqbjNlUHozX2g1N1lsaVJIZ25LWVNSN0dpWTZ1SEVVRld4ZENuNGI?oc=5","date":"2026-03-20","type":"deal","source":"pharmaphorum","summary":"Novartis snaps up PI3Kα breast cancer drug in $3bn deal - pharmaphorum","headline":"Novartis snaps up PI3Kα breast cancer drug in $3bn deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}